Cargando…

CARs: a new approach for the treatment of autoimmune diseases

The development of chimeric antigen receptor (CAR)-based therapeutic interventions represented a breakthrough in cancer treatment. Following the success of the CAR-T-cell strategy, this novel therapeutic approach has been applied to other diseases, including autoimmune diseases. Using CAR-T cells to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yeting, Yuan, Yeshuang, Zhang, Bo, Zhang, Xuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science China Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641699/ https://www.ncbi.nlm.nih.gov/pubmed/36346550 http://dx.doi.org/10.1007/s11427-022-2212-5

Ejemplares similares

Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases
por: Chen, Yuehong, et al.
Publicado: (2019)

CAR-Based Therapy for Autoimmune Diseases: A Novel Powerful Option
por: Műzes, Györgyi, et al.
Publicado: (2023)

CAR T cells for treating autoimmune diseases
por: Blache, Ulrich, et al.
Publicado: (2023)

New Strategies for the Treatment of Solid Tumors with CAR-T Cells
por: Zhang, Hao, et al.
Publicado: (2016)

Proximity-enabled covalent binding of IL-2 to IL-2Rα selectively activates regulatory T cells and suppresses autoimmunity
por: Zhang, Bo, et al.
Publicado: (2023)

Modern Advances in CARs Therapy and Creating a New Approach to Future Treatment
por: Sadowski, Karol, et al.
Publicado: (2022)

Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
por: Zmievskaya, Ekaterina, et al.
Publicado: (2021)

CARs—A New Perspective to HCMV Treatment
por: Bednar, Christopher, et al.
Publicado: (2021)

Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges
por: Riet, Tobias, et al.
Publicado: (2022)

Emerging Approaches for Solid Tumor Treatment Using CAR-T Cell Therapy
por: Chung, Hyunmin, et al.
Publicado: (2021)

Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System
por: Chountoulesi, Maria, et al.
Publicado: (2020)

New development in CAR-T cell therapy
por: Wang, Zhenguang, et al.
Publicado: (2017)

Enhancement of bioactivity, thermal stability and tumor retention by self-fused concatenation of green fluorescent protein
por: Hu, Jin, et al.
Publicado: (2021)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)

Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR”
por: Teppert, Karin, et al.
Publicado: (2022)

Potential roles of extracellular vesicles in the pathophysiology, diagnosis, and treatment of autoimmune diseases
por: Tian, Jing, et al.
Publicado: (2020)

Engineering CAR-T cells
por: Zhang, Cheng, et al.
Publicado: (2017)

Rationally designed approaches to augment CAR-T therapy for solid tumor treatment
por: Zhu, Chaojie, et al.
Publicado: (2023)

New cell sources for CAR-based immunotherapy
por: Mazinani, Marzieh, et al.
Publicado: (2023)

CAR-T Cells for the Treatment of Lung Cancer
por: Chocarro, Luisa, et al.
Publicado: (2022)

CAR T-Cell Production Using Nonviral Approaches
por: Lukjanov, Viktor, et al.
Publicado: (2021)

Intelligent tunable CAR-T cell therapy leads the new trend
por: Cheng, Jiayi, et al.
Publicado: (2023)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021)

CAR-T cells and CAR-Tregs targeting conventional type-1 dendritic cell suppress experimental autoimmune encephalomyelitis
por: Moorman, Cody D., et al.
Publicado: (2023)

Systemic Autoimmune Diseases
por: Shi, Guixiu, et al.
Publicado: (2013)

Genetic Fusion of Transacting Activator of Transcription Peptide to Cyclized Green Fluorescence Protein Improves Stability, Intracellular Delivery, and Tumor Retention
por: Shi, Jianquan, et al.
Publicado: (2021)

Target selection for CAR-T therapy
por: Wei, Jianshu, et al.
Publicado: (2019)

Prospect of Prostate Cancer Treatment: Armed CAR-T or Combination Therapy
por: Jiang, Yao, et al.
Publicado: (2022)

Seatbelts in CAR therapy: How Safe Are CARS?
por: Minagawa, Kentaro, et al.
Publicado: (2015)

CAR-T Cells in the Treatment of Ovarian Cancer: A Promising Cell Therapy
por: Zhang, Xi-Wen, et al.
Publicado: (2023)

New Biomarkers in Autoimmune Disease
por: Shi, Guixiu, et al.
Publicado: (2017)

The Application of Nanobody in CAR-T Therapy
por: Bao, Chaolemeng, et al.
Publicado: (2021)

CAR T-Cells for CNS Lymphoma: Driving into New Terrain?
por: Karschnia, Philipp, et al.
Publicado: (2021)

Recent Advances in BTK Inhibitors for the Treatment of Inflammatory and Autoimmune Diseases
por: Zhang, Datong, et al.
Publicado: (2021)

Advances in Systems Biology Approaches for Autoimmune Diseases
por: Kim, Ho-Youn, et al.
Publicado: (2014)

Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997–2020)
por: Ivica, Nikola A., et al.
Publicado: (2021)

Emerging CAR T Cell Strategies for the Treatment of AML
por: Vishwasrao, Paresh, et al.
Publicado: (2022)

CAR-NK Cells in the Treatment of Solid Tumors
por: Wrona, Ewa, et al.
Publicado: (2021)

Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders
por: Brummer, Tobias, et al.
Publicado: (2021)

Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases
por: Liu, Jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2sbjlel2nke64lsvkq1rhl8ik9